(Q54212928)

26 May 2018

title

Autologous bone marrow transplantation in adults with non-Hodgkin's lymphoma: a Southwest Oncology Group study. (English)

1 reference

26 May 2018

author

Frederick R. Appelbaum

3

object named as

Appelbaum FR

1 reference

26 May 2018

Saez R

1

1 reference

26 May 2018

Dahlberg S

2

1 reference

26 May 2018

Hartsock RJ

4

1 reference

26 May 2018

Lemaistre F

5

1 reference

26 May 2018

Coltman CA Jr

6

1 reference

26 May 2018

Fisher RI

7

1 reference

26 May 2018

publication date

1 March 1994

1 reference

26 May 2018

published in

Hematological Oncology

1 reference

26 May 2018

volume

12

1 reference

26 May 2018

page(s)

75-85

1 reference

26 May 2018

issue

2

1 reference

26 May 2018

Autologous marrow transplantation for malignant lymphoma: a report of 101 cases from Seattle

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900120205

7 January 2021

High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900120205

7 January 2021

Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with a poor prognosis

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900120205

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900120205

7 January 2021

https://api.crossref.org/works/10.1002%2FHON.2900120205

1 reference

7 January 2021

Autologous bone marrow transplantation in B-cell non-Hodgkin's lymphoma: very low treatment-related mortality in 100 patients in sensitive relapse

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900120205

7 January 2021

Massive therapy and autologous bone marrow transplantation in pediatric and young adults Burkitt's lymphoma (30 courses on 28 patients: a 5-year experience).

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900120205

7 January 2021

Autologous bone marrow transplantation for adult poor-risk lymphoblastic lymphoma in first remission

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900120205

7 January 2021

Intensive chemotherapy with high doses of BCNU, etoposide, cytosine arabinoside, and melphalan (BEAM) followed by autologous bone marrow transplantation: toxicity and antitumor activity in 26 patients with poor-risk malignancies

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900120205

7 January 2021

The role of autologous bone marrow transplantation in 46 adult patients with non-Hodgkin's lymphomas

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900120205

7 January 2021

High-dose carmustine, etoposide, and cisplatin and autologous bone marrow transplantation for relapsed and refractory lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FHON.2900120205

7 January 2021

Identifiers

DOI

10.1002/HON.2900120205

1 reference

26 May 2018

PubMed ID

8070756

1 reference

26 May 2018